Ebola Antibody

Scientists have found a hidden weak spot shared by all five known types of the deadly Ebola virus and successfully targeted it with two antibodies which blocked its ability to invade human cells.

The World Health Organization (WHO) has declared the Ebola emergency over, but action is still needed to fully develop effective vaccines and prepare the world for future outbreaks, experts said on Thursday.

Scientists have created a two-antibody cocktail that was able to cure monkeys infected with the deadly Ebola virus, revealed a new study.

A single monoclonal antibody isolated from a human survivor of Ebola virus disease (EVD) completely protects monkeys from the lethal virus, and could hold promise as a potential treatment for infected humans, according to new research.

In what could be termed as "silver bullet" for Ebola viruses, a team of researchers has isolated human antibodies from Ebola survivors which can neutralise multiple species of the virus that has killed more than 11,000 people in West Africa in the past two years.

An experimental Ebola vaccine tested on humans in Europe and Africa sparks the production of the antibodies needed to neutralise the deadly virus, a Geneva hospital said Wednesday.

A Thai hospital today claimed to have successfully developed an "antibody treatment" against the dreaded Ebola virus that has killed over 3,000 people in West Africa this year.

In a study that holds promise for developing new drugs against the deadly Ebola virus, a team led by Sachdev Sidhu from the University of Toronto has reported a possible therapy that could help treat patients infected with Sudan Ebola virus (SUDV).

The use of an experimental drug to treat two Americans diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies for the deadly disease. But some health experts fear that debate over extremely limited doses will distract from tried-and-true measures to curb the growing outbreak, like more rapidly identi...

Scientists have found a hidden weak spot shared by all five known types of the deadly Ebola virus and successfully targeted it with two antibodies which blocked its ability to invade human cells.

The World Health Organization (WHO) has declared the Ebola emergency over, but action is still needed to fully develop effective vaccines and prepare the world for future outbreaks, experts said on Thursday.

Scientists have created a two-antibody cocktail that was able to cure monkeys infected with the deadly Ebola virus, revealed a new study.

A single monoclonal antibody isolated from a human survivor of Ebola virus disease (EVD) completely protects monkeys from the lethal virus, and could hold promise as a potential treatment for infected humans, according to new research.

In what could be termed as "silver bullet" for Ebola viruses, a team of researchers has isolated human antibodies from Ebola survivors which can neutralise multiple species of the virus that has killed more than 11,000 people in West Africa in the past two years.

An experimental Ebola vaccine tested on humans in Europe and Africa sparks the production of the antibodies needed to neutralise the deadly virus, a Geneva hospital said Wednesday.

A Thai hospital today claimed to have successfully developed an "antibody treatment" against the dreaded Ebola virus that has killed over 3,000 people in West Africa this year.

In a study that holds promise for developing new drugs against the deadly Ebola virus, a team led by Sachdev Sidhu from the University of Toronto has reported a possible therapy that could help treat patients infected with Sudan Ebola virus (SUDV).

The use of an experimental drug to treat two Americans diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies for the deadly disease. But some health experts fear that debate over extremely limited doses will distract from tried-and-true measures to curb the growing outbreak, like more rapidly identi...